Contrave Insurance Denial Appeal Guide

Contrave (naltrexone/bupropion) is an FDA-approved oral medication for chronic weight management. As a non-GLP-1 option, it's more affordable but still frequently denied by insurers who exclude weight loss medications.

Common Denial Reasons

  • Weight loss medication exclusion
  • Step therapy (lifestyle intervention required first)
  • Not medically necessary
  • Formulary restrictions

Appeal Strategy

  1. Document BMI and comorbidities (same criteria as Wegovy)
  2. Prior weight management attempts
  3. More affordable than GLP-1 options (cost-effectiveness argument)
  4. Dual mechanism: appetite reduction + reward pathway modulation
  5. COR clinical trial data
  6. May be tried AS the step therapy before GLP-1 medications

Cost

Approximately $200-300/month — significantly less than GLP-1 options.

Need Help Writing Your Appeal?

Our AI-powered tool analyzes your denial letter and generates a personalized appeal in minutes. Upload your denial and get started for free.

Start Your Free Appeal

Frequently Asked Questions

Is Contrave covered by insurance?

Coverage varies widely. Many commercial plans cover Contrave with prior authorization and documented medical necessity (BMI ≥30 or ≥27 with comorbidities). Plans that exclude all weight loss medications may not cover it. The manufacturer offers savings cards for eligible patients.

Related Resources